Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790027 | Urologic Oncology: Seminars and Original Investigations | 2018 | 11 Pages |
Abstract
There was no difference between minority-serving and nonminority-serving hospitals in overall survival or receipt of definitive treatment. Black patients suffered worse survival and were less likely to receive definitive treatment for bladder cancer regardless of the type of hospital in which they were treated.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sean A. B.S., Philipp M.D., Alexander P. M.D., Malte W. M.D., Adam S. M.D., Toni K. M.D., Guru P. M.D., Mark A. M.D., M.P.H., Daniel M.D., Mani M.D., Maxine Ph.D., M.P.H., Stuart R. Sc.D., Quoc-Dien M.D.,